| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $72.59M | $35.27M | $26.98M | $14.46M | $11.70M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $319.65M | $245.15M | $216.92M | $131.12M | $77.31M |
| R&D | $240.28M | $172.97M | $156.50M | $81.61M | $44.88M |
| SG&A | $79.37M | $72.18M | $60.43M | $49.51M | $32.44M |
| Operating Income | -$247.06M | -$209.87M | -$189.95M | -$116.65M | -$65.62M |
| Interest Expense | – | – | $3.26M | $3.34M | $2.98M |
| Tax Expense | $152.00K | -$4.76M | $1.46M | -$1.52M | -$1.66M |
| Net Income | -$218.96M | -$169.03M | -$180.66M | -$112.72M | -$66.82M |
| EPS (basic) | -3.1600 | -2.9000 | -5.0800 | -3.8000 | -2.6700 |
| EPS (diluted) | -3.1600 | -2.9000 | -5.0800 | -3.8000 | -2.6700 |
| Shares (diluted) | $69.28M | $58.21M | $35.59M | $29.66M | $25.06M |